Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

ABCL

AbCellera Biologics Inc

Dec 10 • 04:00PM ET

3.02

Dollar change +0.07
Percentage change 2.37	%

Healthcare • Biotechnology • Canada • NASD

Peers: REGN AMGN VRTX MRNA BNTX INCY ALNY NVAX IONS EXEL

| Held by: IBB IDNA SPDW GWX LRNZ AVUS AVSC BBC BIB IBBQ

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.60	Insider Own	24.92%	Shs Outstand	295.16M	Perf Week	3.78%
Market Cap	892.01M	Forward P/E	-	EPS next Y	-0.57	Insider Trans	0.00%	Shs Float	221.75M	Perf Month	11.85%
Income	-175.80M	PEG	-	EPS next Q	-0.13	Inst Own	34.75%	Short Float	7.19%	Perf Quarter	12.27%
Sales	32.96M	P/S	27.06	EPS this Y	-15.13%	Inst Trans	-9.64%	Short Ratio	7.27	Perf Half Y	-11.95%
Book/sh	3.65	P/B	0.83	EPS next Y	3.35%	ROA	-12.10%	Short Interest	15.93M	Perf Year	-37.99%
Cash/sh	2.26	P/C	1.34	EPS next 5Y	-	ROE	-15.55%	52W Range	2.34 - 6.05	Perf YTD	-47.11%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-	ROI	-15.36%	52W High	-50.12%	Beta	0.41
Dividend TTM	-	Quick Ratio	9.34	Sales past 5Y	387.52%	Gross Margin	-179.73%	52W Low	29.34%	ATR (14)	0.16
Dividend Ex-Date	-	Current Ratio	9.34	EPS Y/Y TTM	-33.92%	Oper. Margin	-934.58%	RSI (14)	57.40	Volatility	5.02% 6.00%
Employees	586	Debt/Eq	0.07	Sales Y/Y TTM	-34.59%	Profit Margin	-533.32%	Recom	1.22	Target Price	12.29
Option/Short	Yes / Yes	LT Debt/Eq	0.06	EPS Q/Q	-75.40%	Payout	-	Rel Volume	1.05	Prev Close	2.95
Sales Surprise	-15.26%	EPS Surprise	-36.66%	Sales Q/Q	-1.39%	Earnings	Nov 05 BMO	Avg Volume	2.19M	Price	3.02
SMA20	5.50%	SMA50	9.40%	SMA200	-8.99%	Trades		Volume	2,302,945	Change	2.37%

Date	Action	Analyst	Rating Change	Price Target Change
Aug-20-24	Downgrade	The Benchmark Company	Buy → Hold
Feb-22-24	Upgrade	The Benchmark Company	Hold → Buy	$9
Dec-05-23	Initiated	KeyBanc Capital Markets	Overweight	$6
Nov-06-23	Downgrade	The Benchmark Company	Buy → Hold
Oct-13-23	Resumed	Piper Sandler	Overweight	$20
Feb-28-23	Initiated	Cowen	Outperform
Dec-15-22	Initiated	Goldman	Buy	$30
Nov-16-22	Initiated	Truist	Buy	$29
Dec-21-21	Initiated	The Benchmark Company	Buy	$27
Nov-19-21	Initiated	Piper Sandler	Overweight	$33
Jan-05-21	Initiated	SVB Leerink	Outperform	$45
Jan-05-21	Initiated	Stifel	Buy	$59
Jan-05-21	Initiated	Credit Suisse	Outperform	$52
Jan-05-21	Initiated	BMO Capital Markets	Outperform	$48
Jan-05-21	Initiated	Berenberg	Buy	$53

Show Previous Ratings

Nov-21-24 04:05PM	AbCellera to Present at Upcoming Investor Conferences in December and January (Business Wire)
Nov-07-24 10:05AM	AbCellera Presents Data on Applications of T-Cell Engager Platform at SITC 2024 (Business Wire)
Nov-05-24 11:17AM	Q3 2024 Abcellera Biologics Inc Earnings Call (Thomson Reuters StreetEvents) -5.88%
02:11AM	AbCellera Biologics Inc (ABCL) Q3 2024 Earnings Call Highlights: Navigating Challenges with ... (GuruFocus.com)
Nov-04-24 11:00PM	AbCellera Biologics (ABCL) Q3 2024 Earnings Call Transcript (Motley Fool) +5.86%
05:55PM	Loading…
05:55PM	AbCellera Biologics Inc. (ABCL) Reports Q3 Loss, Misses Revenue Estimates (Zacks)
04:05PM	AbCellera Reports Q3 2024 Business Results (Business Wire)
Nov-01-24 09:06AM	AbCellera Biologics Inc (ABCL) Q3 2024: Everything You Need To Know Ahead Of Earnings (GuruFocus.com)
Oct-22-24 04:05PM	AbCellera to Present at Upcoming Investor Conferences in November 2024 (Business Wire)
Oct-16-24 08:58AM	Is AbCellera Biologics Inc. (ABCL) the Penny Stock with the Biggest Upside Potential According to Analysts? (Insider Monkey)
Oct-04-24 09:00AM	AbCellera Announces Presentation on T-cell Engager Platform at the Society for Immunotherapy of Cancer (SITC) Annual Meeting 2024 (Business Wire)
Sep-26-24 04:05PM	AbCellera to Report Third Quarter 2024 Financial Results on November 4, 2024 (Business Wire)
Sep-01-24 10:26PM	AbCellera Biologics Inc. (ABCL): The Best Multibagger Penny Stock of 2025? (Insider Monkey)
Aug-29-24 08:41PM	10 Best Multibagger Penny Stocks of 2025 (Insider Monkey)
04:05PM	AbCellera to Present at Upcoming Investor Conferences in September (Business Wire)
05:13AM	Loading…
05:13AM	AbCellera Biologics Inc. (ABCL): A Top Contender Among Canadas Best Penny Stocks in 2024 (Insider Monkey)
Aug-07-24 12:45AM	AbCellera Biologics (ABCL) Q2 2024 Earnings Call Transcript (Motley Fool) -7.72%
Aug-06-24 06:15PM	AbCellera Biologics Inc. (ABCL) Reports Q2 Loss, Misses Revenue Estimates (Zacks)
04:05PM	AbCellera Reports Q2 2024 Business Results (Business Wire)
Aug-01-24 06:32AM	AbCellera and Lilly broadens antibody discovery partnership (Pharmaceutical Technology) -6.44%
Jul-31-24 09:00AM	AbCellera and Lilly Expand Collaboration to Develop Antibody Medicines (Business Wire)
Jul-21-24 05:37AM	Billionaires Are Buying These 2 Beaten-Down Stocks. Are They Smart Buys for Your Portfolio? (Motley Fool)
Jul-09-24 12:00PM	AbCellera Biologics (ABCL) Upgraded to Buy: Here's What You Should Know (Zacks)
Jun-25-24 04:05PM	AbCellera to Report Second Quarter 2024 Financial Results on August 6, 2024 (Business Wire)
Jun-13-24 05:40AM	Down 57%, Is AbCellera Biologics a Buy on the Dip? (Motley Fool)
May-28-24 04:05PM	AbCellera to Present at the Goldman Sachs 45th Annual Global Healthcare Conference on June 10, 2024 (Business Wire) +5.97%
May-13-24 06:00AM	3 Stock Gems Hiding in the Nasdaq (InvestorPlace)
May-08-24 11:03AM	AbCellera Biologics Inc. (NASDAQ:ABCL) Q1 2024 Earnings Call Transcript (Insider Monkey)
07:01AM	Q1 2024 Abcellera Biologics Inc Earnings Call (Thomson Reuters StreetEvents)
04:30AM	AbCellera Biologics (ABCL) Q1 2024 Earnings Call Transcript (Motley Fool)
08:57PM	Loading…
May-07-24 08:57PM	ABCL Stock Earnings: AbCellera Biologics Beats EPS, Misses Revenue for Q1 2024 (InvestorPlace)
06:05PM	AbCellera Biologics Inc. (ABCL) Reports Q1 Loss, Misses Revenue Estimates (Zacks)
06:01PM	AbCellera Biologics Inc (ABCL) Q1 2024 Earnings: Misses Revenue and Net Loss Estimates (GuruFocus.com)
04:05PM	AbCellera Reports Q1 2024 Business Results (Business Wire)
May-01-24 09:00AM	AbCellera, Viking Global Investors, and ArrowMark Partners Collaborate to Launch New Biotech Companies (Business Wire)
Apr-30-24 10:01AM	Analysts Estimate AbCellera Biologics Inc. (ABCL) to Report a Decline in Earnings: What to Look Out for (Zacks)
Apr-08-24 12:05PM	AbCellera Presents Data on T-Cell Engagers Against Four Tumor Targets at AACR 2024 (Business Wire)
Apr-03-24 04:05PM	AbCellera to Report First Quarter 2024 Financial Results on May 7, 2024 (Business Wire)
Mar-27-24 04:30PM	The 7 Best Penny Stocks to Buy in Q2 2024 (InvestorPlace)
Mar-26-24 05:25PM	Billionaire Investor Stan Druckenmiller and Insiders Are Piling Into These 11 Stocks (Insider Monkey) -6.33%
Mar-19-24 04:05PM	AbCellera to Present at the Bloom Burton Healthcare Conference on April 16, 2024 (Business Wire)
Mar-11-24 09:00AM	AbCellera to Collaborate with Biogen to Discover Therapeutic Antibodies for Neurological Conditions (Business Wire)
Mar-05-24 04:30PM	AbCellera Announces Four Presentations on T-Cell Engagers at AACR 2024 (Business Wire)
Feb-26-24 06:55AM	3 Highly Rated Biotech Stocks to Buy for 300% Gains (InvestorPlace)
Feb-23-24 04:30PM	AbCellera Announces Resignation of Board Member (Business Wire)
Feb-22-24 08:15PM	AbCellera to Present at Upcoming Investor Conferences in March (Business Wire)
Feb-21-24 09:22AM	AbCellera Biologics Inc. (NASDAQ:ABCL) Q4 2023 Earnings Call Transcript (Insider Monkey) -9.42%
07:09AM	Q4 2023 Abcellera Biologics Inc Earnings Call (Thomson Reuters StreetEvents)
Feb-20-24 11:00PM	AbCellera Biologics (ABCL) Q4 2023 Earnings Call Transcript (Motley Fool)
07:00PM	AbCellera Biologics Inc. (ABCL) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
04:57PM	AbCellera Biologics Inc (ABCL) Faces Net Loss in FY 2023 Amid Strategic Shifts (GuruFocus.com)
04:05PM	AbCellera Reports Full Year 2023 Business Results (Business Wire)
Jan-30-24 01:02PM	Baillie Gifford Adjusts Stake in AbCellera Biologics Inc (GuruFocus.com) -5.55%
Jan-23-24 04:05PM	AbCellera to Report Full Year 2023 Financial Results on February 20, 2024 (Business Wire)
Jan-15-24 09:30AM	3 Growth Stocks That Could Go Parabolic in 2024 (Motley Fool)
Jan-03-24 09:40AM	Is AbCellera Biologics (ABCL) Outperforming Other Medical Stocks This Year? (Zacks)
Dec-20-23 04:05PM	AbCellera to Present at the 42nd Annual J.P. Morgan Healthcare Conference on January 10, 2024 (Business Wire)
Dec-16-23 01:00PM	AI Meets Biotech: 3 Top Stocks Transforming Medical Science (InvestorPlace)
Dec-11-23 03:30PM	16 Best Penny Stocks To Buy For 2024 (Insider Monkey)
Nov-16-23 04:05PM	AbCellera to Present at the Piper Sandler 35th Annual Healthcare Conference on November 30, 2023 (Business Wire)
Nov-03-23 12:05PM	AbCellera Presents New Data on Two T-Cell Engager Programs at SITC 2023 (Business Wire) +6.09%
10:51AM	AbCellera Biologics Inc. (NASDAQ:ABCL) Q3 2023 Earnings Call Transcript (Insider Monkey)
08:42AM	Q3 2023 Abcellera Biologics Inc Earnings Call (Thomson Reuters StreetEvents)
05:55AM	Prelude Therapeutics Inc (PRLD) Reports Q3 Financial Results and Strategic Pipeline Progress (GuruFocus.com)
05:30AM	AbCellera Biologics (ABCL) Q3 2023 Earnings Call Transcript (Motley Fool)
Nov-02-23 05:56PM	AbCellera Biologics Inc (ABCL) Reports Q3 2023 Earnings: Revenue Drops to $7 Million (GuruFocus.com) +7.52%
04:05PM	AbCellera Reports Q3 2023 Business Results (Business Wire)
Nov-01-23 04:05PM	Prelude Therapeutics and AbCellera Enter Partnership to Develop First-in-Class Precision Antibody Drug Conjugates in Oncology (GlobeNewswire)
Oct-31-23 04:05PM	AbCellera to Present at the Jefferies London Healthcare Conference on November 14, 2023 (Business Wire)
Oct-26-23 10:02AM	Earnings Preview: AbCellera Biologics Inc. (ABCL) Q3 Earnings Expected to Decline (Zacks)
Oct-11-23 04:05PM	AbCellera to Report Third Quarter 2023 Financial Results on November 2, 2023 (Business Wire) -9.34%
Sep-29-23 12:43PM	25 Biggest Stocks with Negative Beta (Insider Monkey)
Sep-27-23 09:00AM	AbCellera Announces Two T-Cell Engager Presentations at SITC 2023 (Business Wire)
Sep-20-23 05:02PM	AbCellera Expands Multi-Target Antibody Discovery Collaboration with Regeneron (Business Wire)
Sep-14-23 07:03PM	Insider Buying: Veronique Lecault Acquires 20,000 Shares of AbCellera Biologics Inc (GuruFocus.com)
Sep-13-23 09:00AM	AbCellera Announces Collaboration with Incyte to Accelerate the Discovery and Development of Therapeutic Antibodies in Oncology (Business Wire)
Aug-31-23 10:12PM	11 Cheap Small-Cap Stocks to Buy Before the Next Breakout (Insider Monkey) -6.03%
07:37AM	10 Stocks That Could 10X Over the Next 10 Years (Insider Monkey)
Aug-19-23 10:44AM	Billionaire Stan Druckenmillers Small-Cap Stock Picks (Insider Monkey)
Aug-04-23 10:23AM	Q2 2023 Abcellera Biologics Inc Earnings Call (Thomson Reuters StreetEvents) -13.34%
01:00AM	AbCellera Biologics (ABCL) Q2 2023 Earnings Call Transcript (Motley Fool)
Aug-03-23 05:35PM	AbCellera Biologics Inc. (ABCL) Reports Q2 Loss, Lags Revenue Estimates (Zacks)
04:05PM	AbCellera Reports Q2 2023 Business Results (Business Wire)
Jul-26-23 01:17PM	10 Best Canadian Stocks Under $10 (Insider Monkey)
Jul-25-23 09:55AM	Does AbCellera Biologics Inc. (ABCL) Have the Potential to Rally 242.09% as Wall Street Analysts Expect? (Zacks)
Jul-24-23 04:05PM	AbCellera Announces that the U.S. Patent Trial and Appeal Board Has Denied Berkeley Lights Request for Rehearing (Business Wire)
Jul-08-23 08:43PM	Looking for Biotech AI Stocks? 3 Names That Will Benefit From the AI Boom (InvestorPlace)
Jul-06-23 04:05PM	AbCellera to Report Second Quarter 2023 Financial Results on August 3, 2023 (Business Wire)
Jun-17-23 09:52AM	AbCellera Biologics Insiders Added US$4.2m Of Stock To Their Holdings \ (Simply Wall St.)
May-30-23 06:50AM	Daily Vickers Top Buyers & Sellers for 05/30/2023 (Argus Research)
May-29-23 04:05PM	AbCellera to Present at the Goldman Sachs 44th Annual Global Healthcare Conference on June 13, 2023 (Business Wire)
May-27-23 08:43AM	Strong week for AbCellera Biologics (NASDAQ:ABCL) shareholders doesn't alleviate pain of one-year loss (Simply Wall St.)
May-24-23 02:32PM	UPDATE 1-AbCellera to make C$701 million co-investment in Canada (Reuters)
01:56PM	AbCellera to make C$701 million co-investment in Canada (Reuters)
01:30PM	These Small-Cap Biotech Stocks Have the Wind at Their Back (TheStreet.com)
01:10PM	AbCellera Partners with the Governments of Canada and British Columbia to Advance Drug Development Capabilities and Infrastructure that Will Accelerate Innovative Medicines to Patients (Business Wire)
May-14-23 02:57PM	7 Growth Stocks That Could Double Your Money in 2023 (InvestorPlace)
May-06-23 08:03AM	AbCellera Biologics First Quarter 2023 Earnings: EPS Misses Expectations (Simply Wall St.)
May-05-23 10:13AM	Q1 2023 Abcellera Biologics Inc Earnings Call (Thomson Reuters StreetEvents) -9.38%
12:30AM	AbCellera Biologics (ABCL) Q1 2023 Earnings Call Transcript (Motley Fool)

AbCellera Biologics, Inc. engages in the development of therapeutic antibodies. It offers antibody discovery platform that searches, decodes and analyzes natural immune systems to find antibodies that can be developed to prevent and treat disease. The company was founded by Carl Lars G. Hensen, Kathleen Lisaingo, Kevin Heyries, Veronique Lecault and Daniel Da Costa on November 8, 2012 and is headquartered in Vancouver, Canada.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

ABCL

AbCellera Biologics Inc

Upgrade your FINVIZ experience